Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?

Nearly fifty million older people suffer from neurodegenerative diseases, including Alzheimer (AD) and Parkinson (PD) disease, a global burden expected to triple by 2050. Such an imminent “neurological pandemic” urges the identification of environmental risk factors that are hopefully avoided to fig...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliano, Sandy, Montemagno, Christopher, Domdom, Marie-Angela, Teisseire, Manon, Brest, Patrick, Klionsky, Daniel J., Hofman, Paul, Pagès, Gilles, Mograbi, Baharia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Commentary and Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472882/
https://www.ncbi.nlm.nih.gov/pubmed/37482676
http://dx.doi.org/10.1080/15548627.2023.2214960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472882/
https://www.ncbi.nlm.nih.gov/pubmed/37482676
http://dx.doi.org/10.1080/15548627.2023.2214960

Ejemplares similares